Fish oil
- Generic Name
- Fish oil
- Brand Names
- Omegaven
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- XGF7L72M0F
- Background
Fish oil is a component of SMOFLIPID, which was FDA approved in July 2016. It is indicated in adults as a source of calories and essential fatty acids for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
...
- Indication
Under FDA approval, fish oil pharmaceuticals are typically products consisting of a combination of the omega-3-fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and are indicated primarily as an adjunct to diet to reduce triglyceride levels in adult patients with severe (>=500 mg/dL) hypertriglyceridemia .
...
- Associated Conditions
- -
- Associated Therapies
- Dietary and Nutritional Therapies, Nutritional supplementation, Parenteral Nutrition
Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease
- Conditions
- First Posted Date
- 2017-03-07
- Last Posted Date
- 2018-12-06
- Lead Sponsor
- Catherine Cibulskis, MD
- Registration Number
- NCT03072667
- Locations
- 🇺🇸
SSM Health Cardinal Glennon Children's Hospital, Saint Louis, Missouri, United States
Effects of Fish Oil on Platelet Function and Coagulation
- Conditions
- Interventions
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Region Skane
- Target Recruit Count
- 12
- Registration Number
- NCT03048981
- Locations
- 🇸🇪
Intensive and perioperative care. Skåne University Hospital. Lund, Lund, Skåne, Sweden
Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in Children
- First Posted Date
- 2016-10-06
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- Cook Children's Health Care System
- Registration Number
- NCT02925520
- Locations
- 🇺🇸
Cook Children's Medical Center, Fort Worth, Texas, United States
Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury
- First Posted Date
- 2016-05-23
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Rush University Medical Center
- Registration Number
- NCT02780193
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants
- First Posted Date
- 2015-08-27
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Pediatrix
- Registration Number
- NCT02534077
- Locations
- 🇺🇸
Children's Hospital of San Antonio, San Antonio, Texas, United States
Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation
- Conditions
- Interventions
- First Posted Date
- 2015-07-31
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Alexandra N. Carey
- Target Recruit Count
- 20
- Registration Number
- NCT02512718
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity
- Conditions
- Interventions
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 48
- Registration Number
- NCT02486042
- Locations
- 🇺🇸
University of California, San Diego Jacobs Medical Center, La Jolla, California, United States
Compassionate Use of Omegaven in Children
- First Posted Date
- 2015-02-24
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 63
- Registration Number
- NCT02370251
- Locations
- 🇺🇸
OU Children's Hospital, Oklahoma City, Oklahoma, United States
Omegaven® as Parenteral Nutrition
- First Posted Date
- 2015-01-08
- Last Posted Date
- 2015-01-08
- Lead Sponsor
- Carle Foundation Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT02334293
- Locations
- 🇺🇸
Carle Foundation Hospital, Urbana, Illinois, United States
Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children
- First Posted Date
- 2014-12-31
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- University of Nebraska
- Registration Number
- NCT02328768
- Locations
- 🇺🇸
Children's Hospital & Medical Center, Omaha, Nebraska, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.